Chronic mucocutaneous candidiasis.
The pathogenesis of chronic mucocutaneous candidiasis is surveyed. Treatment comprises topical antifungal treatment which is insufficient, systemic antifungal treatment which is often followed by a rapid relapse, and specific immunotherapy with live tissue or transfer factor. Combination of systemic antifungal therapy and immunotherapy seems to be the most promising approach. However, no permanent cure has so far been achieved.
D000284:Administration, Oral; D000287:Administration, Topical; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002177:Candidiasis / Q000188:drug therapy / Q000628:therapy*; D002648:Child; D002908:Chronic Disease; D006801:Humans; D007167:Immunotherapy; D007275:Injections, Intravenous; D007501:Iron / Q000627:therapeutic use
D000935:Antifungal Agents; D007501:Iron